Correlation of D-dimer with the Severity of COVID-19 in a Sample of Iraqi Patients in Diyala Governorate

DOI:

https://doi.org/10.36371/port.2024.special.5

Authors

  • Essam Fadel Al-Jumaili Institute of Genetic Engineering and Biotechnology for Postgraduate Studies, University of Baghdad, Baghdad, Iraq.
  • Ayoub Ahmed Zaeel Institute of Genetic Engineering and Biotechnology for Postgraduate Studies, University of Baghdad, Baghdad, Iraq.

The novel coronavirus disease (COVID-19) is an infectious disease that results in acute respiratory infection or the so-called novel coronavirus (SARS-CoV-2).  At the end of 2019, the Corona virus spread rapidly in almost all countries, which led to the imposition of measures of complete distancing and social distancing. Activation of intravascular coagulation is a common feature of disseminated intravascular coagulation in patients with covid-19. To find out if there is a clot inside the blood vessels (DIC) or if there is a clot inside the lung (pulmonary embolism) of the affected person, this is done by detect level of (D-dimer) in the serum of patients.  This study was conducted to investigate the relationship between D-dimer and disease severity in Iraqi patients infected with (SARS -CoV-2) . Samples were collected from Baladruze General Hospital / Diyala and the confirmed epidemiological  hall (Al-Shaheed  Mortada). The total number of the sample is (100) samples, 50 of which are from people in critical condition in quarantine halls and 50 samples are from healthy people not infected with covid-19 to determine the level of D-dimer. The results of the statistical analysis showed a significant difference in the level of (D-dimer) between infected and non-infected peoples, that the mean D-dimer was 3,0977 ± 2,81828 in the infected peoples, and mean D-dimer among non- infected people, 0.2560 ± 0.13611 with high significant (p < 0.0001). It was concluded that there is a relationship between (D-dimer) and disease severity, and it can be used as an indicator of disease progression, taking into account some cases in which the D-dimer level is elevated.

Keywords:

D-dimer, fibrinolysis, COVID-19

[1] Lorente, J. A.; García-Frade, L. J.; Landín, L.; de Pablo, R.; Torrado, C.; Renes, E. and García-Avello, A. (1993). Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest, 103(5), 1536-1542.

[2] Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y. and Cao, B. (2020).Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.The lancet, 395(10223), 497-506.

[3] Cevik, M.; Bamford, C. G. G. and Ho, A. (2020). COVID-19 pandemic—a focused review for clinicians. Clinical Microbiology and Infection, 26(7), 842-847.

[4] Chen, N.; Zhou, M.; Dong, X.; Qu, J.; Gong, F.; Han, Y.; Qiu, Y.; Wang, J.; Liu, Y and Wei, Y. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 395,507–513.

[5] Weitz, J.I.; Fredenburgh, J.C, and Eikelboom, J.W. (2017). A test in context: Ddimer. J Am Coll Cardiol,70, 2411–2420.

[6] Bockenstedt, P. (2003). D-dimer in venous thromboembolism. N Engl J Med. 349:1203–1204.

[7] Naik, R. P.; Wilson, J. G.; Ekunwe, L.; Mwasongwe, S.; Duan, Q.; Li, Y. and Reiner, A. P. (2016). Elevated D-dimer levels in African Americans with sickle cell trait. Blood, The Journal of the American Society of Hematology, 127(18), 2261- 2263.

[8] Levi, M.; Thachil, J.; Iba T. and Levy JH (2020). Coagulation abnormalities and thrombosis in patients with covid-19. Lancet Haematol. 7: e438–e440.

[9] Wichmann, D.; Sperhake, J.P.; Lütgehetmann, M.; Steurer, S.; Edler, C.; Heinemann, A.; Heinrich, F.; Mushumba, H.; Kniep, I. and Schröder, A.S. (2020). Autopsy findings and venous thromboembolism in patients with COVID- 19: a prospective cohort study. Ann Intern Med. 173,268–277.

[10] Pan, F.; Yang, L.; Li, Y.; Liang, B.; Li, L.; Ye, T. and Zheng, C. (2020). Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study. International journal of medical sciences, 17(9), 1281.

[11] Wang, P.; Sha, J.; Meng, M.; Wang, C.; Yao, Q.; Zhang, Z., and Chu, Y. (2020). Risk factors for severe COVID-19 in middle-aged patients without comorbidities: a multicentre retrospective study. Journal of translational medicine, 18(1), 1-12.

[12] Gul, M. H.; Htun, Z. M.; and Inayat, A. (2021). Role of fever and ambient temperature in COVID-19. Expert Review of Respiratory Medicine, 15(2), 171-173.

[13] Alonso-Fernández, A.; Toledo-Pons, N.; Cosío, B. G.; Millán, A.; Calvo, N.;Ramón, L. and Sala-Llinas, E. (2020). Prevalence of pulmonary embolism in patients with covid-19 pneumonia and high D-dimer values: A prospective study. PLoS One, 15(8), e0238216.Alonso-Fernández et al., 2020.

Al-Jumaili, E. F. ., & Zaeel, A. A. (2024). Correlation of D-dimer with the Severity of COVID-19 in a Sample of Iraqi Patients in Diyala Governorate. Journal Port Science Research, 7(issue), 30–33. https://doi.org/10.36371/port.2024.special.5

Downloads

Download data is not yet available.